Back to search

Article

Enhancement of a STING Agonist Vaccine for Tuberculosis Using Locally Supercharged MS2 Viral Capsids

2026-07-09

Abstract excerpt

<h4>ABSTRACT</h4> Mycobacterium tuberculosis (Mtb) infection kills more people worldwide than any other pathogen. While the Bacille Calmette-Guérin (BCG) vaccine for Mtb has been widely used for over a century, it provides insufficient protection to eradicate this disease. One of our labs has recently established that a protein antigen (H1) can be combined with a STING pathway agonist to achieve strong protection...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bc9496a6-3641-5b5f-94be-c77b18aaa781
DOI
10.64898/2026.07.03.736450
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Enhancement of a STING Agonist Vaccine for Tuberculosis Using Locally Supercharged MS2 Viral CapsidsDOI 10.64898/2026.07.03.736450
Select a neighboring publication to make it the new centre.